SLCO1B1 and endometrial cancer: Using the chi-square test to compare carrier proportions between the case and control groups, we found that rs2900478 in SLCO1B1 and rs17601876 in CYP19A2 displayed significantly different distributions, indicating a potential association with endometrial cancer.